- Home
- FLGC vs RANI Comparison
FLGC vs RANI Comparison
Compare FLGC & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- RANI
- Stock Information
- Founded
- FLGC 2019
- RANI 2012
- Country
- FLGC United States
- RANI United States
- Employees
- FLGC N/A
- RANI N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- RANI Medicinal Chemicals and Botanical Products
- Sector
- FLGC Health Care
- RANI Health Care
- Exchange
- FLGC Nasdaq
- RANI Nasdaq
- Market Cap
- FLGC 15.9M
- RANI 17.0M
- IPO Year
- FLGC 2021
- RANI 2021
- Fundamental
- Price
- FLGC $0.69
- RANI $0.65
- Analyst Decision
- FLGC Buy
- RANI Strong Buy
- Analyst Count
- FLGC 2
- RANI 4
- Target Price
- FLGC $4.00
- RANI $7.75
- AVG Volume (30 Days)
- FLGC 104.1K
- RANI 331.2K
- Earning Date
- FLGC 08-11-2025
- RANI 08-05-2025
- Dividend Yield
- FLGC N/A
- RANI N/A
- EPS Growth
- FLGC N/A
- RANI N/A
- EPS
- FLGC N/A
- RANI N/A
- Revenue
- FLGC $53,260,000.00
- RANI $1,200,000.00
- Revenue This Year
- FLGC N/A
- RANI N/A
- Revenue Next Year
- FLGC N/A
- RANI N/A
- P/E Ratio
- FLGC N/A
- RANI N/A
- Revenue Growth
- FLGC N/A
- RANI N/A
- 52 Week Low
- FLGC $0.42
- RANI $0.46
- 52 Week High
- FLGC $2.11
- RANI $4.19
- Technical
- Relative Strength Index (RSI)
- FLGC 55.93
- RANI 61.01
- Support Level
- FLGC $0.62
- RANI $0.52
- Resistance Level
- FLGC $0.72
- RANI $0.68
- Average True Range (ATR)
- FLGC 0.05
- RANI 0.04
- MACD
- FLGC 0.00
- RANI 0.03
- Stochastic Oscillator
- FLGC 75.00
- RANI 83.92
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.